Eli Lilly and CompanyLLYNYSE
Loading
Net Income ScalingExpanding
Percentile Rank100
3Y CAGR+49.0%
5Y CAGR+27.2%
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
3Y CAGR
+49.0%/yr
vs +17.9%/yr prior
5Y CAGR
+27.2%/yr
Recent acceleration
Acceleration
+31.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $20.64B | +94.9% |
| 2024 | $10.59B | +102.1% |
| 2023 | $5.24B | -16.1% |
| 2022 | $6.24B | +11.9% |
| 2021 | $5.58B | -9.9% |
| 2020 | $6.19B | -25.5% |
| 2019 | $8.32B | +157.4% |
| 2018 | $3.23B | +1683.5% |
| 2017 | $-204.10M | -107.5% |
| 2016 | $2.74B | - |